Recent News

• 09.17.2025 - Candel Therapeutics to Present Phase 3 Results of CAN-2409 in Localized Prostate Cancer at ASTRO 2025
• 09.17.2025 - Candel Therapeutics to Present Phase 3 Results of CAN-2409 in Localized Prostate Cancer at ASTRO 2025
• 09.05.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.05.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.04.2025 - Cantor Global Healthcare Conference
• 09.04.2025 - Cantor Global Healthcare Conference
• 09.03.2025 - Citi's 2025 Biopharma Back to School Conference
• 09.03.2025 - Citi's 2025 Biopharma Back to School Conference
• 09.02.2025 - Candel Therapeutics Appoints Renowned Immunotherapy Pioneer Carl H. June, M.D., to Research Advisory Board
• 09.02.2025 - Candel Therapeutics Appoints Renowned Immunotherapy Pioneer Carl H. June, M.D., to Research Advisory Board

Recent Filings

• 08.22.2025 - EFFECT Notice of Effectiveness
• 08.21.2025 - 8-K Current report
• 08.14.2025 - S-3 Registration statement under Securities Act of 1933
• 08.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.14.2025 - EX-99.1 EX-99.1
• 08.14.2025 - 8-K Current report